Lexicon Pharmaceuticals, Inc.
US ˙ NasdaqCM ˙ US5288723027

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Jeffrey L Wade. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Jeffrey L Wade har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:LXRX / Lexicon Pharmaceuticals, Inc. President and CFO 324.214
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Jeffrey L Wade. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb LXRX / Lexicon Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i LXRX / Lexicon Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2023-09-14 LXRX WADE JEFFREY L 10.000 1,3800 10.000 1,3800 13.800 154 3.5800 22.000 159,42
2023-06-20 LXRX WADE JEFFREY L 10.000 2,3350 10.000 2,3350 23.350
2023-06-20 LXRX WADE JEFFREY L 2.000 2,3250 2.000 2,3250 4.650
2017-11-14 LXRX WADE JEFFREY L 2.000 9,4809 2.000 9,4809 18.962

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

LXRX / Lexicon Pharmaceuticals, Inc. Insider Trades
Insidersalg LXRX / Lexicon Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i LXRX / Lexicon Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

LXRX / Lexicon Pharmaceuticals, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Jeffrey L Wade som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2024-02-29 2024-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -37.691 324.214 -10,41 2,62 -98.750 849.441
2024-02-29 2024-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 49.113 361.905 15,70
2024-02-29 2024-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 37.274 312.792 13,53
2024-02-29 2024-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11.177 275.518 4,23
2023-09-14 2023-09-14 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
P - Purchase 10.000 264.341 3,93 1,38 13.800 364.791
2023-06-20 2023-06-20 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
P - Purchase 2.000 254.341 0,79 2,32 4.650 591.343
2023-06-20 2023-06-20 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
P - Purchase 10.000 252.341 4,13 2,34 23.350 589.216
2023-03-01 2023-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -30.255 242.341 -11,10 2,17 -65.653 525.880
2023-03-01 2023-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 37.273 272.596 15,84
2023-03-01 2023-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11.176 235.323 4,99
2023-03-01 2023-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 30.467 224.147 15,73
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -11.177 22.353 -33,33
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -30.466 30.467 -50,00
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -25.290 0 -100,00
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -25.773 193.680 -11,74 2,85 -73.453 551.988
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11.177 219.453 5,37
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 30.466 208.276 17,13
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 25.290 177.810 16,58
2022-02-14 2022-02-10 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
A - Award 111.820 111.820
2022-02-14 2022-02-10 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 335.470 335.470
2022-02-11 2021-04-14 5 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
G - Gift -4.500 152.520 -2,87
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -30.467 60.933 -33,33
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -25.290 25.290 -50,00
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -9.555 0 -100,00
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -2.797 0 -100,00
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -26.584 157.020 -14,48 7,19 -191.139 1.128.974
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 30.467 183.604 19,90
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 25.290 153.137 19,78
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 9.555 127.847 8,08
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.797 118.292 2,42
2021-02-16 2021-02-11 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 100.600 100.600
2021-02-16 2021-02-11 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
A - Award 33.530 33.530
2020-04-24 2020-04-22 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -9.651 115.495 -7,71 1,96 -18.916 226.370
2020-04-24 2020-04-22 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
A - Award 26.525 125.146 26,90
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -25.290 50.580 -33,33
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -9.555 9.555 -50,00
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -2.798 2.797 -50,01
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -4.495 0 -100,00
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -16.025 98.621 -13,98 2,77 -44.389 273.180
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 25.290 114.646 28,30
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 9.555 89.356 11,97
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.798 79.801 3,63
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4.495 77.003 6,20
2020-02-10 2020-02-06 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 274.200 274.200
2020-02-10 2020-02-06 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
A - Award 91.400 91.400
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -9.555 19.110 -33,33
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -2.798 5.595 -33,34
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -4.495 4.495 -50,00
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -5.807 0 -100,00
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -8.639 72.508 -10,65 5,51 -47.601 399.519
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 9.555 81.147 13,35
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.798 71.592 4,07
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4.495 68.794 6,99
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.807 64.299 9,93
2019-02-08 2019-02-07 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
A - Award 75.870 75.870
2019-02-08 2019-02-07 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 140.900 140.900
2019-02-08 2018-08-01 5 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
G - Gift -1.000 58.492 -1,68
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -2.797 8.393 -25,00
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -4.495 8.990 -33,33
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -5.807 5.807 -50,00
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -2.929 0 -100,00
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -6.133 59.492 -9,35 8,53 -52.314 507.467
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.797 65.625 4,45
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4.495 62.828 7,71
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.807 58.333 11,06
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.929 52.526 5,91
2018-02-12 2018-02-08 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 79.550 79.550
2018-02-12 2018-02-08 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
A - Award 28.665 28.665
2018-02-12 2017-12-15 5 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
G - Gift -1.000 49.597 -1,98
2017-11-14 2017-11-14 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
P - Purchase 2.000 50.597 4,12 9,48 18.962 479.705
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -4.495 13.485 -25,00
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -5.807 11.614 -33,33
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -2.928 2.929 -49,99
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -2.429 0 -100,00
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -6.455 48.597 -11,73 16,45 -106.185 799.421
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4.495 55.052 8,89
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.807 50.557 12,98
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.928 44.750 7,00
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.429 41.822 6,17
2017-02-13 2017-02-09 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
A - Award 11.190 11.190
2017-02-13 2017-02-09 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 44.770 44.770
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -5.807 17.421 -25,00
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -2.929 5.857 -33,34
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -2.428 2.429 -49,99
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -2.785 0 -100,00
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3.815 39.393 -8,83 9,07 -34.602 357.295
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.807 43.208 15,53
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.929 37.401 8,50
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.428 34.472 7,58
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.785 32.044 9,52
2016-02-16 2016-02-11 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
A - Award 17.980 17.980
2016-02-16 2016-02-11 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 71.940 71.940
2015-03-03 2015-03-02 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -20.500 61.500 -25,00
2015-03-03 2015-03-02 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -17.000 34.000 -33,33
2015-03-03 2015-03-02 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -19.500 19.500 -50,00
2015-03-03 2015-03-02 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -18.750 0 -100,00
2015-03-03 2015-03-02 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -20.718 204.821 -9,19 0,94 -19.475 192.532
2015-03-03 2015-03-02 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 20.500 225.539 10,00
2015-03-03 2015-03-02 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 17.000 205.039 9,04
2015-03-03 2015-03-02 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 19.500 188.039 11,57
2015-03-03 2015-03-02 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 18.750 168.539 12,52
2015-02-09 2015-02-05 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 650.400 650.400
2015-02-09 2015-02-05 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
A - Award 162.600 162.600
2014-03-03 2014-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Restricted Stock Units (Phantom Stock)
M - Exercise -17.000 51.000 -25,00
2014-03-03 2014-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Restricted Stock Units (Phantom Stock)
M - Exercise -19.500 39.000 -33,33
2014-03-03 2014-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Restricted Stock Units (Phantom Stock)
M - Exercise -18.750 18.750 -50,00
2014-03-03 2014-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Common Stock
F - Taxes -16.297 149.789 -9,81 1,92 -31.290 287.595
2014-03-03 2014-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Common Stock
M - Exercise 17.000 166.086 11,40
2014-03-03 2014-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Common Stock
M - Exercise 19.500 149.086 15,05
2014-03-03 2014-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Common Stock
M - Exercise 18.750 129.586 16,92
2014-02-10 2014-02-06 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Stock Option (Right to Buy)
A - Award 328.000 328.000
2014-02-10 2014-02-06 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Restricted Stock Units (Phantom Stock)
A - Award 82.000 82.000
2013-03-01 2013-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Restricted Stock Units (Phantom Stock)
M - Exercise -19.500 58.500 -25,00
2013-03-01 2013-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Restricted Stock Units (Phantom Stock)
M - Exercise -18.750 37.500 -33,33
2013-03-01 2013-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Common Stock
F - Taxes -10.461 110.836 -8,62 1,98 -20.713 219.455
2013-03-01 2013-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Common Stock
M - Exercise 19.500 121.297 19,16
2013-03-01 2013-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Common Stock
M - Exercise 18.750 101.797 22,58
2013-02-12 2013-02-08 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Stock Option (Right to Buy)
A - Award 272.000 272.000
2013-02-12 2013-02-08 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Restricted Stock Units (Phantom Stock)
A - Award 68.000 68.000
2013-02-04 2013-01-31 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Restricted Stock Units (Phantom Stock)
M - Exercise -31.600 0 -100,00
2013-02-04 2013-01-31 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Common Stock
F - Taxes -10.317 83.047 -11,05 2,11 -21.769 175.229
2013-02-04 2013-01-31 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Common Stock
M - Exercise 31.600 93.364 51,16
2012-03-01 2012-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Restricted Stock Units (Phantom Stock)
M - Exercise -18.750 56.250 -25,00
2012-03-01 2012-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Common Stock
F - Taxes -4.959 61.764 -7,43 1,78 -8.827 109.940
2012-03-01 2012-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Common Stock
M - Exercise 18.750 66.723 39,08
2012-02-17 2012-02-15 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Stock Option (Right to Buy)
A - Award 312.000 312.000
2012-02-17 2012-02-15 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Restricted Stock Units (Phantom Stock)
A - Award 78.000 78.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)